Successful isavuconazole treatment for pulmonary mucormycosis in a patient intolerant to liposomal amphotericin B with pharmacokinetic insights: A case report.

This case highlights the efficacy of IVZ therapy for mucormycosis and the potential utility of TDM in a specific patient population. Further research is needed to elucidate the optimal IVZ dosing and monitoring strategies to ensure safe and efficacious treatment.